141 results
Page 3 of 8
8-K
EX-10.2
jmjk 680d251qgw01
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-10.1
l39801a ei
13 Aug 21
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
atnn 3o3lu7y99
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
S-3ASR
my1dl4jh9p9zzzkdq3zt
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
sgpynem
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-5.1
x9q0pgthjty9
10 Aug 20
Automatic shelf registration
5:01pm
424B5
dhzzdh
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-5.1
ha29gxzm
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
8-K
EX-1.1
bnzit rvmzo80jhgau5
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
mpgm 1g2dkcn70dp9
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-10.1
lzr6d4l7a00 fbf1ynzp
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
na8o7
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
9435i1 yi3f8vnj
22 Jan 20
Prospectus supplement for primary offering
5:31pm